• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性肺泡蛋白沉积症的长期随访和治疗。

Long-term follow-up and treatment of congenital alveolar proteinosis.

机构信息

Dr. von Haunersches Kinderspital, University of Munich, Munich, Germany.

出版信息

BMC Pediatr. 2011 Aug 17;11:72. doi: 10.1186/1471-2431-11-72.

DOI:10.1186/1471-2431-11-72
PMID:21849033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3175167/
Abstract

BACKGROUND

Clinical presentation, diagnosis, management and outcome of molecularly defined congenital pulmonary alveolar proteinosis (PAP) due to mutations in the GM-CSF receptor are not well known.

CASE PRESENTATION

A 2 1/2 years old girl was diagnosed as having alveolar proteinosis. Whole lung lavages were performed with a new catheter balloon technique, feasible in small sized airways. Because of some interstitial inflammation in the lung biopsy and to further improve the condition, empirical therapy with systemic steroids and azathioprin, and inhaled and subcutaneous GMCSF, were used. Based on clinical measures, total protein and lipid recovered by whole lung lavages, all these treatments were without benefit. Conversely, severe respiratory viral infections and an invasive aspergillosis with aspergilloma formation occurred. Recently the novel homozygous stop mutation p.Ser25X of the GMCSF receptor alpha chain was identified in the patient. This mutation leads to a lack of functional GMCSF receptor and a reduced response to GMCSF stimulation of CD11b expression of mononuclear cells of the patient. Subsequently a very intense treatment with monthly lavages was initiated, resulting for the first time in complete resolution of partial respiratory insufficiency and a significant improvement of the overall somato-psychosocial condition of the child.

CONCLUSIONS

The long term management from early childhood into young adolescence of severe alveolar proteinosis due to GMCSF receptor deficiency requires a dedicated specialized team to perform technically demanding whole lung lavages and cope with complications.

摘要

背景

由于 GM-CSF 受体突变导致的分子定义的先天性肺泡蛋白沉积症(PAP)的临床表现、诊断、治疗和转归尚不清楚。

病例介绍

一名 2 岁半的女孩被诊断为肺泡蛋白沉积症。使用新的气囊导管技术进行全肺灌洗,该技术适用于小气道。由于肺活检中有一些间质炎症,为了进一步改善病情,我们经验性地使用了全身类固醇和硫唑嘌呤、吸入和皮下 GMCSF 治疗。基于临床措施、全肺灌洗中总蛋白和脂质的恢复情况,所有这些治疗都没有效果。相反,发生了严重的呼吸道病毒感染和侵袭性曲霉病并形成曲霉肿。最近,在患者中发现了 GM-CSF 受体α链的新型纯合终止突变 p.Ser25X。该突变导致 GM-CSF 受体功能缺失和患者单核细胞对 GMCSF 刺激的 CD11b 表达反应降低。随后,我们开始进行每月一次的强烈灌洗治疗,这是首次完全缓解部分呼吸功能不全,并显著改善了患儿的整体身体-心理社会状况。

结论

GM-CSF 受体缺乏导致的严重肺泡蛋白沉积症从幼儿期到青少年期的长期管理需要一个专门的专业团队来进行技术要求高的全肺灌洗,并应对并发症。

相似文献

1
Long-term follow-up and treatment of congenital alveolar proteinosis.先天性肺泡蛋白沉积症的长期随访和治疗。
BMC Pediatr. 2011 Aug 17;11:72. doi: 10.1186/1471-2431-11-72.
2
A newly identified novel variant in the CSF2RA gene in a child with pulmonary alveolar proteinosis: a case report.一名患有肺泡蛋白沉积症儿童的CSF2RA基因中新发现的新型变异:病例报告。
J Med Case Rep. 2017 May 2;11(1):122. doi: 10.1186/s13256-017-1285-4.
3
Combined-modality therapy for pulmonary alveolar proteinosis in a remote setting: a case report.偏远地区肺泡蛋白沉积症的联合治疗模式:一例报告。
BMC Pulm Med. 2019 Mar 12;19(1):61. doi: 10.1186/s12890-019-0822-x.
4
Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile.老年起病的遗传性肺泡蛋白沉积症及其细胞因子谱。
BMC Pulm Med. 2017 Feb 17;17(1):40. doi: 10.1186/s12890-017-0382-x.
5
Hereditary pulmonary alveolar proteinosis. Could it be triggered by Mycoplasma pneumoniae pneumonia?遗传性肺泡蛋白沉积症。它会由肺炎支原体肺炎引发吗?
Respir Med. 2013 Jan;107(1):134-8. doi: 10.1016/j.rmed.2012.07.005. Epub 2012 Dec 1.
6
Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy.遗传性肺气泡蛋白沉积症:发病机制、临床表现、诊断和治疗。
Am J Respir Crit Care Med. 2010 Nov 15;182(10):1292-304. doi: 10.1164/rccm.201002-0271OC. Epub 2010 Jul 9.
7
Pulmonary alveolar proteinosis: time to shift?肺泡蛋白沉积症:是时候做出改变了吗?
Expert Rev Respir Med. 2015 Jun;9(3):337-49. doi: 10.1586/17476348.2015.1035259. Epub 2015 Apr 12.
8
Whole lung lavage combined with Granulocyte-macrophage colony stimulating factor inhalation for an adult case of refractory pulmonary alveolar proteinosis.全肺灌洗联合吸入粒细胞巨噬细胞集落刺激因子治疗1例成人难治性肺泡蛋白沉积症
BMC Pulm Med. 2014 May 19;14:87. doi: 10.1186/1471-2466-14-87.
9
Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.肺泡蛋白沉积症综合征:发病机制、诊断与治疗
Curr Opin Pulm Med. 2009 Sep;15(5):491-8. doi: 10.1097/MCP.0b013e32832ea51c.
10
Granulocyte macrophage colony stimulating factor therapy for pulmonary alveolar proteinosis.粒细胞巨噬细胞集落刺激因子治疗肺泡蛋白沉积症
J Assoc Physicians India. 2013 Mar;61(3):209-11.

引用本文的文献

1
A Case Report of Pulmonary Alveolar Proteinosis Masquerading as Respiratory Distress Syndrome in Preterm Neonates.一例伪装成呼吸窘迫综合征的早产儿肺泡蛋白沉积症病例报告。
Cureus. 2024 Jul 4;16(7):e63866. doi: 10.7759/cureus.63866. eCollection 2024 Jul.
2
Interstitial lung disease in infancy and early childhood: a clinicopathological primer.婴儿和幼儿期的间质性肺病:临床病理基础。
Eur Respir Rev. 2022 Mar 9;31(163). doi: 10.1183/16000617.0251-2021. Print 2022 Mar 31.
3
T Cell Antifungal Immunity and the Role of C-Type Lectin Receptors.

本文引用的文献

1
Whole-lung lavage in infants and children with pulmonary alveolar proteinosis.婴幼儿肺泡蛋白沉积症的全肺灌洗术
Paediatr Anaesth. 2010 Dec;20(12):1118-23. doi: 10.1111/j.1460-9592.2010.03442.x.
2
Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB.由 CSF2RB 中单个碱基缺失引起的成人遗传性肺泡蛋白沉积症。
J Med Genet. 2011 Mar;48(3):205-9. doi: 10.1136/jmg.2010.082586. Epub 2010 Nov 12.
3
Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy.
T 细胞抗真菌免疫与 C 型凝集素受体的作用。
Trends Immunol. 2020 Jan;41(1):61-76. doi: 10.1016/j.it.2019.11.007. Epub 2019 Dec 5.
4
The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies suggests novel therapeutic opportunities.人源性 GM-CSF 自身抗体抑制 GM-CSF 的机制提示了新的治疗机会。
MAbs. 2018 Oct;10(7):1018-1029. doi: 10.1080/19420862.2018.1494107. Epub 2018 Sep 12.
5
Novel method of noninvasive ventilation supported therapeutic lavage in pulmonary alveolar proteinosis proves to relieve dyspnea, normalize pulmonary function test results and recover exercise capacity: a short communication.无创通气支持治疗性灌洗治疗肺泡蛋白沉积症的新方法被证明可缓解呼吸困难、使肺功能测试结果正常化并恢复运动能力:一篇简短通讯
J Thorac Dis. 2018 Apr;10(4):2467-2473. doi: 10.21037/jtd.2018.04.12.
6
Role of the β Common (βc) Family of Cytokines in Health and Disease.β 共用(βc)家族细胞因子在健康和疾病中的作用。
Cold Spring Harb Perspect Biol. 2018 Jun 1;10(6):a028514. doi: 10.1101/cshperspect.a028514.
7
Whole-Genome Sequencing of a Family with Hereditary Pulmonary Alveolar Proteinosis Identifies a Rare Structural Variant Involving CSF2RA/CRLF2/IL3RA Gene Disruption.对遗传性肺泡蛋白沉积症家族的全基因组测序鉴定出一个罕见的结构变异,涉及 CSF2RA/CRLF2/IL3RA 基因缺失。
Sci Rep. 2017 Feb 24;7:43469. doi: 10.1038/srep43469.
8
Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study.自身免疫性肺泡蛋白沉积症中皮质类固醇给药的结局:一项回顾性队列研究
BMC Pulm Med. 2015 Aug 12;15:88. doi: 10.1186/s12890-015-0085-0.
9
GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders.患有严重肺泡蛋白沉积症和血液系统疾病的儿童及成人中的GATA2缺乏症。
BMC Pulm Med. 2015 Aug 12;15:87. doi: 10.1186/s12890-015-0083-2.
10
Characterization of CSF2RA mutation related juvenile pulmonary alveolar proteinosis.与CSF2RA突变相关的青少年肺泡蛋白沉积症的特征
Orphanet J Rare Dis. 2014 Nov 26;9:171. doi: 10.1186/s13023-014-0171-z.
遗传性肺气泡蛋白沉积症:发病机制、临床表现、诊断和治疗。
Am J Respir Crit Care Med. 2010 Nov 15;182(10):1292-304. doi: 10.1164/rccm.201002-0271OC. Epub 2010 Jul 9.
4
Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis.吸入粒细胞/巨噬细胞集落刺激因子治疗肺泡蛋白沉积症。
Am J Respir Crit Care Med. 2010 Jun 15;181(12):1345-54. doi: 10.1164/rccm.200906-0978OC. Epub 2010 Feb 18.
5
Respiratory disease in Niemann-Pick type C2 is caused by pulmonary alveolar proteinosis.尼曼-匹克病 C2 型的呼吸疾病是由肺泡蛋白沉积症引起的。
Clin Genet. 2010 Feb;77(2):119-30. doi: 10.1111/j.1399-0004.2009.01325.x. Epub 2009 Dec 10.
6
Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages.肺泡蛋白沉积症,一种由 GM-CSF 刺激巨噬细胞功能障碍引起的原发性免疫缺陷病。
Curr Opin Immunol. 2009 Oct;21(5):514-21. doi: 10.1016/j.coi.2009.09.004. Epub 2009 Sep 30.
7
Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA.由CSF2RA基因突变引起的家族性肺泡蛋白沉积症。
J Exp Med. 2008 Nov 24;205(12):2703-10. doi: 10.1084/jem.20080990. Epub 2008 Oct 27.
8
Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1.X染色体假常染色体区域1中GM-CSFRα基因缺失所致的肺泡蛋白沉积症。
J Exp Med. 2008 Nov 24;205(12):2711-6. doi: 10.1084/jem.20080759. Epub 2008 Oct 27.
9
Bronchioalveolar lavage with perfluorochemical liquid during conventional ventilation.在传统通气期间用全氟化学液体进行支气管肺泡灌洗。
Pediatr Crit Care Med. 2007 Sep;8(5):486-8. doi: 10.1097/01.PCC.0000282757.25347.6C.
10
Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report.赖氨酸尿性蛋白不耐受继发肺泡蛋白沉积症患者成功进行全肺灌洗:一例报告
Orphanet J Rare Dis. 2007 Mar 26;2:14. doi: 10.1186/1750-1172-2-14.